Skip to main content
Type at least 3 characters

3,019 articles

Clinical Trial

Accepted on 21 Aug 2025

Preliminarily Evaluation the Safety and Immunogenicity of Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp) in Participants Aged 6 Years and above: A Blinded and Randomised, and Controlled Phase I Clinical Trial

in Vaccines and Molecular Therapeutics

  • Xiaoyu Liu
  • Chen Wei
  • Haitao Huang
  • Jingxuan Wan
  • Yajun Li
  • Feiyu Wang
  • Siwen Li
  • Ying Wang
  • Xuewen Wang
  • Xue Wang
Frontiers in Immunology
doi 10.3389/fimmu.2025.1616574
  • 286 views

Original Research

Accepted on 18 Aug 2025

Immunization route-mediated differences in long-term maturation of humoral immune response induced by adenovirus vector-based COVID-19 vaccine Sputnik V in nonhuman primates

in Vaccines and Molecular Therapeutics

  • Amir I. Tukhvatulin
  • Ilya V. Gordeychuk
  • Alina S. Dzharullaeva
  • Inna V. Dolzhikova
  • Ekaterina O. Bayurova
  • Anna V. Kovyrshina
  • Alla S. Zhitkevich
  • Daria V. Avdoshina
  • Stanislav A. Gulyaev
  • Tatiana V. Gulyaeva
Frontiers in Immunology
doi 10.3389/fimmu.2025.1634187
  • 129 views

Original Research

Published on 18 Aug 2025

A genome-wide association study identifies new loci associated with response to SARS-CoV-2 mRNA-1273 vaccine in a cohort of healthy healthcare workers

in Vaccines and Molecular Therapeutics

  • Antonio José Cabrera-Serrano
  • Lucía Ruiz-Durán
  • Juan Francisco Gutiérrez-Bautista
  • María Carretero-Fernández
  • Rob ter Horst
  • Yang Li
  • Fernando Jesús Reyes-Zurita
  • Francisco José García-Verdejo
  • Mihai G. Netea
  • Pedro Sánchez-Rovira
Frontiers in Immunology
doi 10.3389/fimmu.2025.1639825
  • 839 views